Table 2 Range of Model parameters for sensitivity analyses (results expressed in %)

Access to ANC

36.5

36–85

[18, 19]

HIV testing in ANC

80.1

80–100

[19]

ARV prophylactic coverage in ANC for HIV-infected women

67

50–74

[2, 19]

CD4 cell count quantification for infected women in ANC

22.9

22–100

[19]

ART eligible in ANC

60

40–60

[19]

ART coverage for eligible women in ANC

25

25–32

[3, 19]

Natural history of HIV MTCT at birth

22

15–25

[23, 28]

Treatment Effectiveness

[21, 23]

-Short course ARV (reduction)

86.7

86–95

-Long course ARV/ ART (reduction)

93.7

93–95

Incidence rate among postpartum lactating women

2.0

0.2–3.8

[31]